Clinical Trial

A Phase I Clinical Study of a Single Dose of KLA480

Name: A Phase I Clinical Study of a Single Dose of KLA480 — clinical trial record (NCT07030790)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

Primary purpose: To evaluate the safety and tolerability of KLA480 injection after a single subcutaneous injection in healthy participants. Secondary purpose: To evaluate the pharmacokinetic (PK) characteristics of KLA480 injection after a single subcutaneous injection in healthy participants.

Trial Details

NCT Number	NCT07030790
Lead Sponsor	Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
Conditions	Healthy Participants
Enrollment	20 participants
Start Date	2025-05-17
Primary Completion	2026-12-31 (estimated)
Study Completion	2027-03-01 (estimated)
Updated on ClinicalTrials.gov	2025-06-22